Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-07-04 | 2023-10-03 | 197282 |
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-11-23 | 2024-03-28 | 211316 |
| TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2024-01-25 | 2024-03-18 | 217220 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
| NEO-LARYNGOBIS | 135MG | SUPPOSITORY | Resolved | 2023-06-16 | 2023-10-03 | 195198 |
| TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Resolved | 2022-01-27 | 2022-03-09 | 153706 |
| TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Actual shortage | 2024-01-11 | 2024-01-18 | 215734 |
| TEVA-RANITIDINE | 150MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1510 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1607 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1748 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
| TEVA-CAPECITABINE | 150MG | TABLET | Resolved | 2017-08-01 | 2018-05-11 | 17862 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-17 | 68569 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-10 | 68572 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86927 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-10-24 | 92669 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-11-08 | 92672 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |